SANTA CLARITA, Calif., July 11, 2017 -- BioSolar, Inc. (OTCQB:BSRC) (“BioSolar” or the “Company”), a developer of breakthrough energy storage technology and materials, today shared commentary from multiple media outlets detailing the Company’s recent corporate milestones, specifically the completed laboratory tests that indicate its Si alloy anode material, when incorporated in lithium-ion batteries, can achieve significantly higher capacity than existing commercialized materials.
In an article published by Chemical Engineering Magazine detailing BioSolar’s novel approach to developing a Si Alloy and its potential to lower Li-ion battery costs, the author notes that BioSolar “has demonstrated a novel Si-Alloy Nanocomposite anode that accommodates Si’s expansion, maintains electrode capacity and allows for the use of less expensive raw materials.” The article also quotes BioSolar’s CEO Dr. David Lee discussing the importance of using lower cost raw material sources to lower costs without negatively impacting performance. Further, the article highlights the Company’s efforts to minimize tiny defects during manufacturing of the anode, and maintain efficacy during charge and discharge.
In an article entitled Battery Test Powers BioSolar Share Price Higher published by the San Fernando Valley Business Journal, the author notes recognition from the capital markets following the Company’s recent announcements. The article also highlights BioSolar’s emphasis on safety following high profile lithium-ion battery catastrophes, such as the Samsung Galaxy Note 7 explosions. Dr. Lee is quoted, saying “the goal of the lithium-ion industry is to increase capacity and lower cost, but at the same time try to make them (batteries) safer.” The publication also highlighted BioSolar’s recently announced partnership with South Korean battery maker, Top Battery, in an article from June, entitled "BioSolar Gets Partner."
“We are pleased by the recognition from respected members of the media, both business and technologically-focused publications, that understand the importance of our recent accomplishments and also the greater challenge ahead as we pursue commercialization,” said Dr. Lee. “From a corporate standpoint, we believe in transparent and ongoing communications that provide not only our shareholders with status updates, but also the technology community and potential business partners.”
About BioSolar, Inc.
BioSolar is developing a breakthrough technology to increase the storage capacity, lower the cost and extend the life of lithium-ion batteries. A battery contains two major parts, a cathode and an anode, that function together as the positive and negative sides. BioSolar initially focused its development effort on high capacity cathode materials since most of today's Li-ion batteries are "cathode limited." With the goal of creating the company's next generation super battery technology, BioSolar is currently investigating high capacity anode materials recognizing the fact that the overall battery capacity is determined by combination of both cathode and anode. By integrating BioSolar's high capacity cathode or anode, battery manufacturers will be able to create a super lithium-ion battery that can double the range of a Tesla, power an iPhone for two days straight, or store daytime solar energy for nighttime use. Founded with the vision of developing breakthrough energy technologies, BioSolar's previous successes include the world's first UL approved bio-based back sheet for use in solar panels.
To learn more about BioSolar, please visit our website at http://www.biosolar.com.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.
CONTACT INFORMATION Investor Relations Contact: Tom Becker BioSolar, Inc. [email protected] (877) 904-3733 For Media Inquiries: Eric Fischgrund FischTank Marketing and PR [email protected]


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



